Endless Health is a technology company.
Endless Health has raised $480K across 1 funding round.
Endless Health has raised $480K in total across 1 funding round.
Endless Health has raised $480K in total across 1 funding round.
Endless Health's investors include Antler, TA Ventures, Brian O'Kelley, Hannah Bronfman.
Endless Health is a technology-driven health company specializing in preventive and personalized care focused on cardiovascular and metabolic health. It offers at-home testing kits for key blood biomarkers, combined with AI-powered or live coaching and progress tracking to help individuals and wellness practitioners prevent cardiovascular diseases and improve longevity. The company serves both individual consumers seeking convenient health monitoring and wellness professionals aiming to personalize care and scale their practices sustainably. Endless Health also supports companies by providing health benefits solutions for employees. Since its founding in 2022, it has raised approximately $4.7 million in seed funding and is expanding its clinical trial and preventive medicine services[1][2][4].
Endless Health was founded in 2022 by Cooper Galvin (MS, PhD), Jiabao Li (MDes), and Deji Akinwande, with a mission to make personalized, preventive health accessible and practical. The idea emerged from the urgent need to provide scalable, reliable tools that enable proactive, data-driven health management. Early traction included raising seed funding led by Next Coast Ventures and Asset Management Ventures, and initiating clinical trials for at-home and point-of-care medical devices aimed at longevity and chronic disease prevention. The company was formerly known as Peregrine Biosense and is headquartered in Houston, Texas, with a team that includes experts in engineering and laboratory science[1][3][4].
Endless Health rides the growing trend of preventive and personalized medicine, leveraging digital health technologies and at-home diagnostics to empower individuals and practitioners. The timing is favorable due to increasing consumer demand for convenient, data-driven health management and the healthcare industry's shift toward value-based care and chronic disease prevention. Market forces such as rising cardiovascular disease prevalence and the need for scalable longevity solutions support Endless Health’s growth. By integrating AI, remote testing, and clinical trial services, Endless Health influences the broader ecosystem by enabling more accessible, evidence-based preventive care and accelerating research in longevity and chronic conditions[1][2][6].
Looking ahead, Endless Health is poised to expand its clinical trial offerings and deepen its integration with wellness practices, potentially becoming a key player in the longevity and preventive health space. Trends such as AI-driven health coaching, remote patient monitoring, and personalized medicine will shape its trajectory. Its influence may grow as it helps standardize at-home testing and clinical trial processes, making preventive care more scalable and accessible. Continuous innovation in testing technology and software infrastructure will be critical to maintaining its competitive edge and impact on health outcomes[1][2][6].
Endless Health has raised $480K across 1 funding round. Most recently, it raised $480K Seed in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $480K Seed | Antler, TA Ventures, Brian O'Kelley, Hannah Bronfman |